JP2007161690A - COMPOUND HAVING beta-N-ACETYLGLUCOSAMINIDASE INHIBITORY ACTIVITY - Google Patents

COMPOUND HAVING beta-N-ACETYLGLUCOSAMINIDASE INHIBITORY ACTIVITY Download PDF

Info

Publication number
JP2007161690A
JP2007161690A JP2005364111A JP2005364111A JP2007161690A JP 2007161690 A JP2007161690 A JP 2007161690A JP 2005364111 A JP2005364111 A JP 2005364111A JP 2005364111 A JP2005364111 A JP 2005364111A JP 2007161690 A JP2007161690 A JP 2007161690A
Authority
JP
Japan
Prior art keywords
formula
active substance
compound
glcnacase
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005364111A
Other languages
Japanese (ja)
Other versions
JP5049489B2 (en
Inventor
Hiroshi Kanzaki
浩 神崎
Teruhiko Nitoda
照彦 仁戸田
Hiroichi Usuki
博一 臼木
Hiroshi Komura
啓 小村
Nahoko Yamaji
奈保子 山路
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Okayama University NUC
Suntory Ltd
Original Assignee
Okayama University NUC
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okayama University NUC, Suntory Ltd filed Critical Okayama University NUC
Priority to JP2005364111A priority Critical patent/JP5049489B2/en
Publication of JP2007161690A publication Critical patent/JP2007161690A/en
Application granted granted Critical
Publication of JP5049489B2 publication Critical patent/JP5049489B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/90Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a new compound which exhibits insecticidal/germicidal effect and is useful as a raw material for a safe agricultural and horticultural chemical and a food additive. <P>SOLUTION: The compound is represented by formula (X<SP>-</SP>is a counteranion; D is hydrogen H or deuterium D) in which GlcNAc-(β1,4)-GlcNAc-(β1,4)-GlcNAc is bonded to N-trimethylglucosamine by an α-1-4 bond. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、β−N−アセチルグルコサミニダーゼ(以下、GlcNAcaseとも略称する)阻害活性を有する化合物、それを含有する殺虫・殺菌組成物、農薬、園芸資材、食品添加剤、および食品、ならびにβ−N−アセチルグルコサミニダーゼ阻害活性を有する化合物の製造方法に関する。   The present invention relates to a compound having β-N-acetylglucosaminidase (hereinafter also abbreviated as GlcNAcase) inhibitory activity, an insecticidal / bactericidal composition containing the same, an agrochemical, a gardening material, a food additive, and a food, and β-N -It is related with the manufacturing method of the compound which has acetylglucosaminidase inhibitory activity.

昆虫の成育の過程における、昆虫に特有の生理現象の一つとして脱皮現象が挙げられる。その脱皮には表皮を構成するキチンの分解代謝が不可欠であり、その分解代謝に関与する酵素としてキチナーゼとβ−N−アセチルグルコサミニダーゼとが知られている。GlcNAcase阻害剤の探索研究はこれまでに幅広くなされており、既に多くの化合物が見出されている(例えば非特許文献1参照)。
上記2種の酵素に対する阻害作用物質がいくつか報告されているが、昆虫以外の生物種由来の酵素に対しても阻害するため、特異性がないと報告されてきた。
Pharmacol. Ther., 76, 287−218, (1997)
One of the physiological phenomena unique to insects in the process of insect growth is molting. For the molting, degradation metabolism of chitin constituting the epidermis is indispensable, and chitinase and β-N-acetylglucosaminidase are known as enzymes involved in the degradation metabolism. Exploratory research for GlcNAcase inhibitors has been extensive so far, and many compounds have already been found (see, for example, Non-Patent Document 1).
Several inhibitory substances against the above two enzymes have been reported, but they have also been reported to have no specificity because they also inhibit enzymes derived from species other than insects.
Pharmacol. Ther. , 76, 287-218, (1997)

本発明者らは、昆虫のβ−N−アセチルグルコサミニダーゼを特異的に阻害する化合物を見出すことができれば、そのような化合物は害虫である昆虫の脱皮を阻害し、昆虫の成育を特異的に妨げることができるから、人畜に安全な有害昆虫の駆除剤を開発し得ることに着目した。したがって、当初の本発明の課題はそのような昆虫のβ−N−アセチルグルコサミニダーゼを特異的に阻害する化合物を見出すことであった。   If we can find compounds that specifically inhibit insect β-N-acetylglucosaminidase, such compounds will inhibit molting of insect pests and specifically prevent insect growth. Therefore, we focused on the possibility of developing safe insect control agents for human livestock. Thus, the original object of the present invention was to find compounds that specifically inhibit such insect β-N-acetylglucosaminidase.

本発明者らは、極めて多数の種々の微生物、特にStreptomyces属、Actinomycete属、Paecilomyces属などに属する微生物、例えば、糸状菌、放線菌の培養物を広く探索した結果、培養物から式I

Figure 2007161690
(式I中、nは0〜5の整数、Xは対アニオンを表す。)
で示される4種類の化合物を4種類の混合物として単離することに成功した。また、式Iで示される化合物を重メタノール処理後、還元することによって、式(II−1)
Figure 2007161690
(式II−1中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
および
式(II−2)
Figure 2007161690
(式II−2中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
で示される化合物の製造に成功するとともに、これらの化合物が昆虫のβ−N−アセチルグルコサミニダーゼに対して特異的に優れた阻害作用を有することを知見した。本発明者らはまたこれらの化合物が人畜に対して低毒または無毒であることを見出した。 The present inventors have extensively searched for a large number of various microorganisms, particularly microorganisms belonging to the genus Streptomyces, Actinomycete, Paecilomyces, etc., for example, filamentous fungi, actinomycetes.
Figure 2007161690
(In formula I, n represents an integer of 0 to 5, and X represents a counter anion.)
Was successfully isolated as a mixture of four compounds. Further, the compound represented by the formula I is treated with deuterated methanol and then reduced to reduce the formula (II-1)
Figure 2007161690
(In formula II-1, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
And formula (II-2)
Figure 2007161690
(In formula II-2, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
In addition to the successful production of the compounds represented by the formula (1), it has been found that these compounds have a particularly excellent inhibitory action on insect β-N-acetylglucosaminidase. The inventors have also found that these compounds are low or non-toxic to livestock.

さらに本発明者らは、これらの化合物が優れた殺菌作用を有することを見出した。またさらに本発明者らは、これらの化合物またはこれらの化合物を含有する組成物が、農園芸用薬剤、食品添加物として有用であることを見出した。   Furthermore, the present inventors have found that these compounds have an excellent bactericidal action. Furthermore, the present inventors have found that these compounds or compositions containing these compounds are useful as agricultural and horticultural drugs and food additives.

すなわち本発明は、
(1)式I

Figure 2007161690
(式I中、nは0〜5の整数、Xは対アニオンを表す。)
または、式II
Figure 2007161690
(式II中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
で示される化合物、
(2)式I
Figure 2007161690
(式I中、nは0〜5の整数、Xは対アニオンを表す。)
または、式II
Figure 2007161690
(式II中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
で示される化合物を含有する殺虫性または殺菌性組成物、
(3)農薬用または園芸用であることを特徴とする、上記(2)に記載の組成物、
(4)食品添加剤用であることを特徴とする、上記(2)に記載の組成物、
(5)上記(1)に記載の化合物を含有することを特徴とする食品、および
(6)上記(1)に記載の化合物を産生し得る微生物を培養し、その培養物から上記(1)に記載の化合物を取得することを特徴とする、上記(1)に記載の化合物の製造方法
に関する。 That is, the present invention
(1) Formula I
Figure 2007161690
(In formula I, n represents an integer of 0 to 5, and X represents a counter anion.)
Or the formula II
Figure 2007161690
(In formula II, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
A compound represented by
(2) Formula I
Figure 2007161690
(In formula I, n represents an integer of 0 to 5, and X represents a counter anion.)
Or the formula II
Figure 2007161690
(In formula II, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
An insecticidal or bactericidal composition comprising a compound represented by:
(3) The composition according to (2) above, which is used for agricultural chemicals or horticulture,
(4) The composition as described in (2) above, which is for food additives,
(5) A food containing the compound according to (1) above, and (6) a microorganism capable of producing the compound according to (1) above, and culturing the above-mentioned (1) from the culture The compound according to (1) is obtained, wherein the compound according to (1) is obtained.

本発明の化合物は、殺虫作用および殺菌作用を示し、農園芸用薬剤または食品添加剤として有用である。   The compound of the present invention exhibits an insecticidal action and a bactericidal action, and is useful as an agricultural or horticultural drug or food additive.

本発明の化合物は、上記式(I−1)、(I−2)、(I−3)、(I−4)、(II−1)、および(II−2)で表される。
上記式中、Xで表される対アニオンは、アニオンであればどのようなものでもよく、特に限定されないが、具体的には例えば、ハロゲン、水酸基、炭酸イオン、炭酸水素イオン、硫酸イオン、重硫酸イオン、シュウ酸イオン、酢酸イオン、蟻酸イオンなどの有機または無機のアニオンが挙げられ、好ましくは炭酸水素イオンである。
式Iで表される4種類の化合物はそれぞれ異性体であり、式(I−1)と(I−2)および式(I−3)と(I−4)は、還元末端の一位がアノマー(α,β)の関係にある。また、式(I−1)と(I−3)および式(I−2)と(I−4)は、還元末端のニ位がエピマーの関係であり、式(I−1)と(I−2)はグルコサミン型、式(I−3)と(I−4)はマンノサミン型になっている。これら4種類のいずれかの異性体およびその任意の混合物はすべて本発明に属するものとする。
The compounds of the present invention are represented by the above formulas (I-1), (I-2), (I-3), (I-4), (II-1), and (II-2).
In the above formula, the counter anion represented by X may be any anion as long as it is an anion, and is not particularly limited. Specifically, for example, halogen, hydroxyl group, carbonate ion, bicarbonate ion, sulfate ion, Organic or inorganic anions such as bisulfate ion, oxalate ion, acetate ion and formate ion can be mentioned, and hydrogen carbonate ion is preferred.
The four types of compounds represented by Formula I are isomers, respectively. In Formulas (I-1) and (I-2) and Formulas (I-3) and (I-4), the first position of the reducing end is It is in the relationship of anomer (α, β). Further, in the formulas (I-1) and (I-3) and the formulas (I-2) and (I-4), the second position of the reducing end is an epimer, and the formulas (I-1) and (I -2) is glucosamine type, and formulas (I-3) and (I-4) are mannosamine type. Any of these four isomers and any mixtures thereof shall belong to the present invention.

上記式Iの化合物は、例えば糸状菌または放線菌、例えばStreptomyces属、Actinomycete属、Paecilomyces属などに属する微生物、好ましくはStreptomyces anulatus種に属する微生物、さらに好ましくはStreptomyces anulatus NBRC13369株などの微生物を培養し、その培養物から式Iで表される化合物を取得することによって製造される。
上記微生物の培養は、自体公知の方法に従って行われる。培養に使用される培地は、例えば炭素源、窒素源、無機塩等を含む通常の栄養培地を用いて培養を行うことができる。炭素源としては、例えばグルコース、廃糖蜜等を用いることができるが、上記Streptomyces anulatus NBRC13369株を培養する場合には、炭素源としてキチン、好ましくはコロイド状のキチンを加えることが好ましい。窒素源としては、例えばアンモニア、硫酸アンモニウム、塩化アンモニウム、硝酸アンモニウム、尿素等をそれぞれ単独もしくは混合して用いることができる。また、無機塩として、例えばリン酸一水素カリウム、リン酸二水素カリウム、硫酸マグネシウム等を使用することができる。この他にも必要に応じて、寒天、アミノ酸、ペプトン、肉エキス、酵母エキス、コーンスティープリカー、カザミノ酸、ビオチン、チアミン等の各種ビタミン等の栄養素を培地に適宜添加することもできるが、上記Streptomyces anulatus NBRC13369株を培養する場合には、富栄養培地では式Iで示される化合物を生産しないこともあるので、適宜培地を選択する必要がある。
The compounds of the above formula I are, for example, filamentous fungi or actinomycetes, for example microorganisms belonging to the genus Streptomyces, Actinomycete, Paecilomyces, preferably microorganisms belonging to the species of Streptomycins species, more preferably microorganisms such as Streptomyces anthulus NBRC13 , By obtaining a compound of formula I from the culture.
The microorganism is cultured according to a method known per se. The medium used for the culture can be cultured using a normal nutrient medium containing, for example, a carbon source, a nitrogen source, an inorganic salt, and the like. As the carbon source, for example, glucose, molasses and the like can be used. However, when culturing the above Streptomyces anuratus NBRC13369 strain, it is preferable to add chitin, preferably colloidal chitin as the carbon source. As the nitrogen source, for example, ammonia, ammonium sulfate, ammonium chloride, ammonium nitrate, urea and the like can be used alone or in combination. As inorganic salts, for example, potassium monohydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate and the like can be used. In addition, nutrients such as various vitamins such as agar, amino acid, peptone, meat extract, yeast extract, corn steep liquor, casamino acid, biotin, thiamine and the like can be appropriately added to the medium as necessary. When culturing Streptomyces anuratus NBRC13369 strain, the compound represented by the formula I may not be produced in the rich medium, so it is necessary to select the medium appropriately.

培養は、通常、通気攪拌、振盪等の好気的条件下または嫌気的条件下、約20℃〜約40℃、好ましくは約25℃〜約40℃の温度で行うことができる。培養時のpHは4〜10、好ましくは5〜8付近の範囲がよく、培養中のpH調整は酸またはアルカリを添加することにより行うことができる。また、培養期間は好ましくは半日〜20日間である。
培養後、培養液をろ過または遠心分離によって、菌体と培養ろ液を分別する。
得られたろ液を例えば、クロマトグラフィーまたは溶媒抽出などの精製手段に付する。精製手段は、公知の手段であってよく、例えば、活性炭カラムクロマトグラフィー、陽イオン交換カラムクロマトグラフィー、陰イオン交換カラムクロマトグラフィー、Sephadex LH−20カラムクロマトグラフィー、Aspipak ES 502Cカラムクロマトグラフィーなどが好ましい例として挙げられる。クロマトグラフィーによって得られる全画分を、生物活性を指標としてスクリーニングする。生物活性としては、GlcNAcase酵素阻害試験による酵素阻害率を指標とする。例えば、そのような酵素阻害試験として、(A)ハスモンヨトウ蛹GlcNAcase阻害試験、(B)子牛腎臓GlcNAcase阻害試験、(C)ヒト胎盤GlcNAcase阻害試験および (D) Aspergillus oryzae GlcNAcase阻害試験が挙げられる。例えば(A)試験に陽性である画分は脱皮する昆虫の成育を阻害する化合物が含まれていることを意味し、そのような阻害作用を示す化合物は脱皮する害虫昆虫の駆除剤として有用である。その他の(B)および(C)試験に陰性である画分は、人畜のGlcNAcaseに対して無害であることを示す。(D)試験に陽性である画分は、芝草の病原菌に抗菌作用を示すことを意味する。したがって、(A)または(D)試験に陽性であり、かつ(B)および(C)試験に陰性である画分は、有害昆虫または有害菌に対して殺虫または殺菌作用を示し、有益動物に安全である化合物を含み得ることを意味するから、このような化合物を含む画分を集める。
Culturing can be usually performed at a temperature of about 20 ° C. to about 40 ° C., preferably about 25 ° C. to about 40 ° C. under aerobic conditions such as aeration agitation and shaking, or anaerobic conditions. The pH during the culture is in the range of 4 to 10, preferably 5 to 8, and the pH during the culture can be adjusted by adding an acid or an alkali. Further, the culture period is preferably half a day to 20 days.
After culturing, the cells are separated from the culture filtrate by filtration or centrifugation.
The obtained filtrate is subjected to purification means such as chromatography or solvent extraction. The purification means may be known means, for example, activated carbon column chromatography, cation exchange column chromatography, anion exchange column chromatography, Sephadex LH-20 column chromatography, Asipak ES 502C column chromatography and the like are preferable. Take as an example. All fractions obtained by chromatography are screened using biological activity as an indicator. As the biological activity, the enzyme inhibition rate by the GlcNAcase enzyme inhibition test is used as an index. Examples of such enzyme inhibition tests include (A) Spodoptera litura GlcNAcase inhibition test, (B) Calf kidney GlcNAcase inhibition test, (C) Human placenta GlcNAcase inhibition test, and (D) Aspergillus oryzae GlcNAcase inhibition test. For example, the fraction that is positive in the test (A) means that a compound that inhibits the growth of insects that molt is included, and a compound that exhibits such an inhibitory action is useful as an insecticide for molting insects. is there. Fractions that are negative for the other tests (B) and (C) indicate that they are harmless to human GlcNAcase. (D) A fraction that is positive in the test means that it exhibits an antibacterial action against turfgrass pathogens. Thus, fractions that are positive for (A) or (D) and negative for (B) and (C) test are insecticidal or bactericidal against harmful insects or fungi and are beneficial to beneficial animals. Fractions containing such compounds are collected, meaning that they can contain compounds that are safe.

さらにこのようにして集められた画分を、例えば、転溶、濃縮、クロマトグラフィー、結晶化、再結晶、蒸留などの精製手段に付して、目的とする例えば、ハスモンヨトウなどの脱皮する農園芸害虫または衛生害虫や植物病原菌の成育を阻害し、他の有用動物に無害な式Iで表される化合物式(I−1)、式(I−2)、式(I−3)、および式(I−4)を得ることができる。またこのようにして得られる式Iで表される化合物は例えば芝草の病原菌に対して優れた抗菌効果を示す。これらの化合物は殺菌作用を示し、人畜のGlcNAcaseに対して活性を示さない、すなわち人畜に対しては無害であるから、例えば農園芸用の殺虫または殺菌剤や食品添加剤として有用である。またさらに、式Iの化合物を還元することによって、式IIで示される化合物式(II−1)および式(II−2)を得ることができ、これら式IIで表される化合物は、式Iで表される化合物と同様な生物活性を示す。これら式中のnとしては0〜5で表されるが、n=2が好ましい。下記する実施例において、n=2である化合物が取得されているが、培養条件、培養物からの活性物質の単離条件によっては、n=2以外の化合物も取得され得る。また、取得された化合物を酵素または酸を使用する公知の加水分解手段に付することによって、培養液中の生成される化合物のnの値よりもnの値がより小さい化合物も取得することができる。
式Iの化合物の還元は、自体公知の方法により行われ得る。例えば、白金触媒、パラジウム触媒などを触媒として用いる接触還元、例えば水素化ホウ素ナトリウム(SBH)、チオ硫酸ナトリウムなどの還元剤を使用する還元など常套の還元手段が便宜に採用され得る。
Further, the fraction collected in this manner is subjected to purification means such as transfer dissolution, concentration, chromatography, crystallization, recrystallization, distillation, etc., and the intended agriculture, horticultural, etc., which peels off the target, for example, Spodoptera litura Compounds of formula (I-1), formula (I-2), formula (I-3), and formulas that inhibit the growth of pests or sanitary pests and phytopathogenic fungi and are harmless to other useful animals (I-4) can be obtained. Further, the compound represented by the formula I thus obtained exhibits an excellent antibacterial effect against, for example, turfgrass pathogens. These compounds exhibit a bactericidal action and do not exhibit activity against GlcNAcase of human livestock, that is, they are harmless to human livestock, and thus are useful, for example, as agricultural or horticultural insecticides or bactericides and food additives. Furthermore, by reducing the compound of the formula I, the compound formulas (II-1) and (II-2) represented by the formula II can be obtained. The compounds represented by the formula II are represented by the formula I It exhibits the same biological activity as the compound represented by N in these formulas is represented by 0 to 5, and n = 2 is preferable. In the examples described below, compounds with n = 2 are obtained, but compounds other than n = 2 may be obtained depending on the culture conditions and the conditions for isolating the active substance from the culture. In addition, by subjecting the obtained compound to a known hydrolysis means using an enzyme or an acid, a compound having a smaller value of n than the value of n of the compound produced in the culture solution can also be obtained. it can.
The reduction of the compound of formula I can be carried out by methods known per se. For example, conventional reduction means such as catalytic reduction using a platinum catalyst, palladium catalyst or the like as a catalyst, for example, reduction using a reducing agent such as sodium borohydride (SBH), sodium thiosulfate, etc. can be conveniently employed.

本発明の化合物またはその塩は、安全性に優れた農薬、例えば、殺虫剤または殺菌剤として使用することができる。特に、哺乳動物や魚介類に対して低毒性で、環境を汚染することもなく、水田、畑、果樹園あるいは非農耕地用の殺虫剤または殺菌剤として極めて安全に使用することができる。   The compound of the present invention or a salt thereof can be used as an agrochemical excellent in safety, for example, an insecticide or a fungicide. In particular, it has low toxicity to mammals and fish and shellfish, and does not pollute the environment, and can be used extremely safely as an insecticide or fungicide for paddy fields, fields, orchards or non-agricultural land.

本発明の化合物またはその塩を農薬、特に、殺虫剤または殺菌剤として使用するにあたっては、一般の農薬のとりうる形態、すなわち、化合物またはその塩の1種または2種以上を使用目的によって適当な液体担体に溶解するか分散させるか、または適当な固体担体と混合するか吸着させ、例えば乳剤、油剤、噴霧剤、水和剤、粉剤、DL(ドリフトレス)型粉剤、粒剤、微粒剤、微粒剤F、フロアブル剤、ドライフロアブル剤、ジャンボ粒剤、錠剤等の製剤として使用する。これらの製剤は必要に応じて、例えば乳化剤、展着剤、浸透剤、湿潤剤、粘漿剤、安定剤等を添加してもよく、自体公知の方法で調製することができる。   When the compound of the present invention or a salt thereof is used as an agrochemical, in particular, an insecticide or a fungicide, a form that can be taken by a general agrochemical, that is, one or more of the compound or a salt thereof is suitable depending on the purpose of use. Dissolved or dispersed in a liquid carrier, or mixed or adsorbed with a suitable solid carrier, for example, emulsion, oil, spray, wettable powder, powder, DL (driftless) type powder, granule, fine granule, Used as preparations such as fine granules F, flowables, dry flowables, jumbo granules, tablets. These preparations may contain, for example, an emulsifier, a spreading agent, a penetrating agent, a wetting agent, a mucilage, a stabilizer and the like, and can be prepared by a method known per se.

本発明組成物は、例えば上記式Iまたは式IIで表される化合物のいずれか1以上の有効成分を製剤の種類に応じて適当な不活性な液体または固体の担体で希釈し、必要に応じて界面活性剤、分散剤又は補助剤等を配合して、上記の製剤を製造する。ここで好適な担体としては、例えば、タルク、ベントナイト、クレー、カオリン、珪藻土、ひる石、酸性白土、滑石粉、ロウ石粉、珪藻土、雲母粉、アルミナ、硫黄粉末、活性炭、炭酸カルシウム、ホワイトカーボン、バーミキュライト、消石灰、珪砂、硫安、尿素、タバコ粉、木粉等の固体担体、イソプロピルアルコール、キシレン、シクロヘキサノン、メチルナフタレン、脂肪酸エステル、植物油、鉱物油、動物油、水等の液体担体が挙げられる。これらの担体は1種または2種以上を適当な割合で混合して製剤製造のために使用される。   In the composition of the present invention, for example, one or more active ingredients of the compounds represented by the above formula I or formula II are diluted with an appropriate inert liquid or solid carrier depending on the kind of the preparation, and if necessary, Then, a surfactant, a dispersing agent or an adjuvant is blended to produce the above preparation. Suitable carriers here include, for example, talc, bentonite, clay, kaolin, diatomaceous earth, vermiculite, acid white clay, talc powder, wax stone powder, diatomaceous earth, mica powder, alumina, sulfur powder, activated carbon, calcium carbonate, white carbon, Examples thereof include solid carriers such as vermiculite, slaked lime, silica sand, ammonium sulfate, urea, tobacco powder, and wood powder, and liquid carriers such as isopropyl alcohol, xylene, cyclohexanone, methylnaphthalene, fatty acid ester, vegetable oil, mineral oil, animal oil, and water. These carriers are used for preparing a preparation by mixing one or more kinds in an appropriate ratio.

界面活性剤及び分散剤としては、例えば、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシンエチレンアルキルフェニルエーテル、ポリオキシエチレンアルキルエーテルサルフェート、アルキルベンゼンスルホネート、ナフタレンスルホネートホルマリン縮合物、ポリオキシエチレンアルキルフェニルエーテルスルホネート等が挙げられる。
補助剤としては、例えば、カルボキシメチルセルロース、ポリビニルアルコール、ポリエチレングルコール、縮合リン酸塩等が挙げられる。
本発明の農園芸用製剤は、上記の成分を混合することにより製造される。これらの製剤は、適宜な濃度に希釈して散布されるか、又は、直接施用される。
Surfactants and dispersants include, for example, polyoxyethylene fatty acid ester, polyoxyethylene castor oil, polyoxyn ethylene alkyl phenyl ether, polyoxyethylene alkyl ether sulfate, alkyl benzene sulfonate, naphthalene sulfonate formalin condensate, polyoxyethylene alkyl phenyl. Examples include ether sulfonate.
Examples of the auxiliary agent include carboxymethyl cellulose, polyvinyl alcohol, polyethylene glycol, condensed phosphate and the like.
The agricultural and horticultural preparation of the present invention is produced by mixing the above components. These preparations are sprayed after being diluted to an appropriate concentration or applied directly.

本発明の組成物は、具体的には、例えば下記のような害虫の防除に適用できる。すなわち、イネクロカメムシ(Scotinophara lurida)、ナシグンバイ(Stephanitis nashi)、ヒメトビウンカ(Laodelphax striatellus)、トビイロウンカ(Nilaparvata lugens)、ツマグロヨコバイ(Nephotettix cincticeps)、ヤノネカイガラムシ(Unaspis yanonensis)、ダイズアブラムシ(Aphis glycines)、ダイコンアブラムシ(Brevicoryne brassicae)、ワタアブラムシ(Aphis gossypii)、セジロウンカ(Sogatella furcifera)、チャノミドリヒメヨコバイ(Empoasca onukii)、クワコナカイガラムシ(Pseudococus comstocki)、ハスモンヨトウ(Spodoptera litura)、コナガ(Plutella xylostella)、モンシロチョウ(Pieris rapae crucivora)、ニカメイガ(Chilo supppressalis)、タマナギンウワバ(Autographa nigrisigna)、タバコガ(Helicoverpa assulta)、アワヨトウ(Pseudaletia separata)、ヨトウガ(Mamestra brassicae)、イネゾウムシ(Echinocnemus squameus)、イネミズゾウムシ(Lissorhoptrus oryzophilus)、ワタミゾウムシ(Anthonomus grandis)、アズキゾウムシ(Callosobruchus chinensis)、シバオサゾウムシ(Sphenophorus venatus)、マメコガネ(Popillia japonica)、ドウガネブイブイ(Anomala cuprea)、コーンルートワームの仲間(Diabrotica spp.)、コロラドハムシ(Leptinotarsa decemlineata)、コメツキムシの仲間(Agriotes spp.)、イエバエ(Musca domestica)、アカイエカ(Culex popiens pallens)、チャバネゴキブリ(Blattella germanica)、クロゴキブリ(Periplaneta fuliginosa)、ヤマトゴキブリ(Periplaneta japonica)、ワモンゴキブリ(Periplaneta americana)、イネシンガレセンチュウ(Aphelenchoides besseyi)、イチゴメセンチュウ(Nothotylenchus acris)、イエシロアリ(Coptotermes formosanus)、ヤマトシロアリ(Reticulitermes speratus)、タイワンシロアリ(Odontotermes formosanus)、ダイコクシロアリ(Cryptotermes domesticus)等の害虫の防除に特に有効である。   Specifically, the composition of the present invention can be applied to, for example, the following pest control. That is, the rice black bug (Scotinophara lurida), Nashigunbai (Stephanitis nashi), small brown planthopper (Laodelphax striatellus), brown planthopper (Nilaparvata lugens), green rice leafhopper (Nephotettix cincticeps), Unaspis yanonensis (Unaspis yanonensis), soybean aphid (Aphis glycines), radish Aphids (Brevicorine brassicae), cotton aphids (Aphis gossypii), white-tailed planthopper (Sogatella furcifera), tea-nosed leafhopper (Empoasca onukii), staghorn beetle (Ps) eudococus comstocki), common cutworm (Spodoptera litura), diamondback moth (Plutella xylostella), cabbage butterfly (Pieris rapae crucivora), rice stem borer (Chilo supppressalis), Tamanagin'uwaba (Autographa nigrisigna), tobacco budworm (Helicoverpa assulta), armyworm (Pseudaletia separata), cabbage armyworm (Mamestra brassicae), weevil (Echinocnemus squameus), rice weevil (Lissohoptrus oryzophilus), cotton weevil (Anthonomus grandis), Zukizoumushi (Callosobruchus chinensis), grass reed weevil (Sphenophorus venatus), Japanese beetle (Popillia japonica), cupreous chafer (Anomala cuprea), corn root worm fellow (Diabrotica spp.), Colorado potato beetle (Leptinotarsa decemlineata), fellow of click beetles (Agriotes spp .), Musca domestica, Culex popiens pallens, German cockroach (Blatella germanica), Black cockroach (Peripraneta friginosa), Japanese cockroach (Petella japonica) ponica), American cockroach (Periplaneta americana), rice Shin Galle nematode (Aphelenchoides besseyi), strawberry menu nematode (Nothotylenchus acris), Formosan subterranean termite (Coptotermes formosanus), Yamato termite (Reticulitermes speratus), Taiwan termites (Odontotermes formosanus), Daikoku termites (Cryptotermes It is particularly effective for controlling pests such as domesticus).

また、本発明の化合物は芝草の病原菌に抗菌作用を示すので、該菌が原因となって生じる芝草に見られる病気、例えばヘルミントスポリウム、フェアリーリング、ダラースポット、ピシウム、ブラウンパッチ、サビ病、イエローパッチなどの治療・予防に有効である。   In addition, since the compound of the present invention exhibits an antibacterial action against turfgrass pathogens, diseases such as helmintosporium, fairy ring, dollar spot, psium, brown patch, rust disease caused by the fungus are observed. It is effective for the treatment and prevention of yellow patches.

例えば、播種または植え付け前の土壌に散布する場合は、10a(アール)当たりの本発明の製剤を、0.8kgから30kg程度として、播種または植え付けの当日から30日程度前に散布すればよい。また、作物が成育中の土壌に対しては、10a当たりの本発明の製剤の量を1kgから50kg程度として、10〜20日間隔で散布すればよい。   For example, when spraying on the soil before sowing or planting, the preparation of the present invention per 10a may be sprayed about 0.8 to 30 kg about 30 days before the day of sowing or planting. Moreover, what is necessary is just to spray to the soil in which the crop is growing at intervals of 10 to 20 days with the amount of the preparation of the present invention per 10a being about 1 kg to 50 kg.

本発明の化合物は人畜無害であり、優れた殺菌効果を示すから食品添加剤として有用であり、食品に添加され、食品の保存期間を顕著に延長することができる。式Iまたは式IIで示される化合物のいずれか1以上を直接食品に添加してもよいし、上記化合物を適当な希釈剤で希釈して食品に添加してもよい。本発明の化合物が添加される食品としては、例えば冷凍すり身、蒲鉾、竹輪、さつま揚げ、魚肉ソーセージ等の魚肉練り製品、ハム、ソーセージ等の畜肉製品、緑茶、ウーロン茶、麦茶、混合茶(ブレンドティー)、コーヒー、コーヒー乳飲料、カフェオーレ、紅茶、ミルクティー、ココア、ミルクココア、ミルクセーキ、汁粉等の低酸性飲料、果汁やフレーバー、機能性素材等を含んだ機能性飲料、スポーツ飲料、栄養補給飲料等の酸性飲料、ポテトサラダ、マカロニサラダ、餃子、シュウマイ、厚焼き玉子、和え物、煮物等の惣菜類、浅漬け等の漬物類、米飯・おかゆ類、豆腐・厚揚げ類、生麺、茹で麺、蒸し麺等の麺類、小豆餡、いも餡、栗餡等の餡類、フラワーペースト、カスタードクリーム等のクリーム類、ハンバーグ、肉団子等の挽肉加工品、ネギトロ、タタキ等の魚肉加工品、カレードーナッツ、中華饅頭(肉まん)等の芯部具材類、親子丼、牛丼、カツ丼等の丼物などが挙げられる。   Since the compound of the present invention is harmless to humans and exhibits an excellent bactericidal effect, it is useful as a food additive and can be added to foods to significantly extend the storage period of foods. Any one or more of the compounds represented by Formula I or Formula II may be added directly to the food, or the compound may be diluted with a suitable diluent and added to the food. Examples of the food to which the compound of the present invention is added include frozen surimi, salmon, bamboo rings, deep-fried sweet potato, fish paste such as fish sausage, meat products such as ham and sausage, green tea, oolong tea, wheat tea, mixed tea (blend tea), Coffee, coffee milk drink, cafe au lait, tea, milk tea, cocoa, milk cocoa, milkshake, low acid beverages such as juice, functional drinks including fruit juices, flavors, functional ingredients, sports drinks, nutritional drinks, etc. Acidic drinks, potato salad, macaroni salad, dumplings, shumai, thick-boiled eggs, side dishes such as seasoning, boiled food, pickles such as shallow pickles, cooked rice / porridge, tofu / deep-fried dishes, raw noodles, boiled noodles, Noodles such as steamed noodles, rice cakes such as red bean rice cake, potato rice cake, chestnut rice cakes, creams such as flower paste and custard cream, hamburger, meat dumplings, etc. Minced meat processed products, Negitoro, fish processed products, such as assault, curry donuts, core ingredient such as Chinese bun (buns), oyakodon, beef bowl, and a bowl of such katsudon.

本発明の式(I−1)、式(I−2)、式(I−3)、および式(I−4)、または式(II−1)および式(II−2)で示される化合物でn=2となる化合物について、以下に実施例を挙げて説明するが、本発明はこれらに限定されるものではない。なお、本発明の実施例で採用された酵素阻害試験方法は下記の通りである。以下に記載する%は、(w/w)%である。   The compound represented by formula (I-1), formula (I-2), formula (I-3), and formula (I-4), or formula (II-1) and formula (II-2) of the present invention In the following, the compound in which n = 2 is described with reference to examples, but the present invention is not limited thereto. In addition, the enzyme inhibition test method employ | adopted in the Example of this invention is as follows. The% described below is (w / w)%.

〔試験例1〕
酵素阻害試験方法
(イ)ハスモンヨトウ蛹GlcNAcase阻害試験法
最初に、ハスモンヨトウ蛹GlcNAcas酵素溶液を、”K.Kawazu,S.Ohnishi, H.Kanzaki and A.Kobayashi: Z.Naturforsch.51c,738−742(1996)”に記載の方法に従って調製した。具体的には次の通りである。
ハスモンヨトウ蛹50gを、0.01%フェニルチオウレア(PTU)を含む14.3mMクエン酸/リン酸/ホウ酸緩衝液(pH7.0)50mL中で摩砕し、ろ過した。ろ液を20,000g、4℃で30分間遠心分離し、その上清をさらに100,000g、4℃で60分間超遠心分離した。その上清に硫酸アンモニウムを60%飽和となるように徐々に添加し、4℃で1時間撹拌した。その液を20,000g、4℃で15分間遠心分離し、その上清を4℃で透析した。この際の透析外液は0.01%PTUを含む14.3mMクエン酸/リン酸/ホウ酸緩衝液(pH7.0)2Lであった。その透析内液をさらに上記と同じ条件で透析し、得られた透析内液を20,000g、4℃で15分間遠心分離し、その上清をハスモンヨトウ蛹GlcNAcas酵素溶液とした。
また、緩衝液として、643mMクエン酸/リン酸/ホウ酸緩衝液(pH6.0) 24μL、基質として、5mM p−ニトロフェニル N−アセチル−β−D−グルコサミニド水溶液16μL、試験試料水溶液として80μL、あるいは対照区として試験試料を含まない水を含む溶液80μLを加えた混合液に、上記の通りハスモンヨトウ蛹より調製したGlcNAcase酵素溶液の14.3mMクエン酸/リン酸/ホウ酸緩衝液(pH6.0)希釈溶液を40μL添加し、よく撹拌後、37℃、60分間反応させた。反応終了後、1.3M水酸化ナトリウム水溶液100μLを添加し、よく撹拌後、直ちに分光光度計により415nmにおける吸光度(a)を測定した。同時に、試験試料を含まない対照区の吸光度(b)を測定した。ここで、対照区へのGlcNAcase酵素溶液の添加量は415nmにおける吸光度(b)が0.500となるような量とした。GlcNAcase阻害率(%)は、[1−(a)/(b)]×100により計算した。
[Test Example 1]
Enzyme Inhibition Test Method (I) Lotus moth GlcNAcase Inhibition Test Method First, the citrus moth GlcNAcas enzyme solution was added to the “K. Kawazu, S. Ohnishi, H. Kanzaki and A. Kobayashi: Z. Naturefor 7: Z. Naturfor7. 1996) ”. Specifically, it is as follows.
50 g of Spodoptera litura was ground in 50 mL of 14.3 mM citrate / phosphate / borate buffer (pH 7.0) containing 0.01% phenylthiourea (PTU) and filtered. The filtrate was centrifuged at 20,000 g and 4 ° C. for 30 minutes, and the supernatant was further ultracentrifuged at 100,000 g and 4 ° C. for 60 minutes. To the supernatant, ammonium sulfate was gradually added so as to be 60% saturated, and stirred at 4 ° C. for 1 hour. The solution was centrifuged at 20,000 g and 4 ° C. for 15 minutes, and the supernatant was dialyzed at 4 ° C. The dialyzed external solution at this time was 2 L of 14.3 mM citrate / phosphate / borate buffer (pH 7.0) containing 0.01% PTU. The dialyzed internal solution was further dialyzed under the same conditions as described above, and the resulting dialyzed internal solution was centrifuged at 20,000 g, 4 ° C. for 15 minutes, and the supernatant was used as a cedar moth GlcNAcas enzyme solution.
Moreover, as buffer solution, 643 mM citrate / phosphate / borate buffer solution (pH 6.0) 24 μL, as substrate 5 mM p-nitrophenyl N-acetyl-β-D-glucosaminide aqueous solution 16 μL, test sample aqueous solution 80 μL, Alternatively, a 14.3 mM citrate / phosphate / borate buffer solution (pH 6.0) of GlcNAcase enzyme solution prepared from Spodoptera litura as described above was added to a mixture obtained by adding 80 μL of a solution containing water not containing a test sample as a control. ) 40 μL of diluted solution was added, stirred well, and reacted at 37 ° C. for 60 minutes. After completion of the reaction, 100 μL of 1.3 M aqueous sodium hydroxide solution was added, and after stirring well, the absorbance (a) at 415 nm was measured immediately using a spectrophotometer. At the same time, the absorbance (b) of the control group not containing the test sample was measured. Here, the amount of the GlcNAcase enzyme solution added to the control group was such that the absorbance (b) at 415 nm was 0.500. The GlcNAcase inhibition rate (%) was calculated by [1- (a) / (b)] × 100.

(ロ)子牛腎臓GlcNAcase阻害試験法
(イ)の方法に準じて、緩衝液および酵素溶液を以下のように変更した。即ち、GlcNAcase酵素溶液としてbovine kidney 由来β−N−アセチルグルコサミニダーゼ(SIGMA社)を、緩衝液として0.025%のBSAと250mMのNaClを含む250mMクエン酸緩衝液(pH5.0)を用いた。他の条件は(イ)に同じである。
(B) Calf kidney GlcNAcase inhibition test method The buffer solution and the enzyme solution were changed as follows according to the method of (A). Specifically, bovine kidney-derived β-N-acetylglucosaminidase (SIGMA) was used as the GlcNAcase enzyme solution, and 250 mM citrate buffer (pH 5.0) containing 0.025% BSA and 250 mM NaCl was used as the buffer. Other conditions are the same as (a).

(ハ)ヒト胎盤GlcNAcase阻害試験法
(イ)の方法に準じて、緩衝液および酵素溶液を以下のように変更した。即ち、GlcNAcase酵素溶液としてヒト胎盤由来β-N−アセチルグルコサミニダーゼ(SIGMA社)を、緩衝液として0.025%のBSAと250mMのNaClを含む250mMクエン酸緩衝液(pH4.3)を用いた。他の条件は(イ)に同じである。
(C) Human placenta GlcNAcase inhibition test method The buffer solution and the enzyme solution were changed as follows according to the method of (a). Specifically, human placenta-derived β-N-acetylglucosaminidase (SIGMA) was used as a GlcNAcase enzyme solution, and a 250 mM citrate buffer (pH 4.3) containing 0.025% BSA and 250 mM NaCl was used as a buffer. Other conditions are the same as (a).

(ニ)Penicillium oxalicum GlcNAcase阻害試験法
(イ)の方法に準じて、緩衝液および酵素溶液を以下のように変更した。即ち、GlcNAcase酵素溶液としてPenicillium oxalicum由来β-N−アセチルヘキソサミニダーゼ(生化学工業社)を、緩衝液として250mMクエン酸緩衝液(pH4.5)を用いた。他の条件は(イ)に同じである。
(D) Penicillium oxalicum GlcNAcase inhibition test method The buffer solution and the enzyme solution were changed as follows according to the method of (a). Specifically, Penicillium oxalicum-derived β-N-acetylhexosaminidase (Seikagaku Corporation) was used as the GlcNAcase enzyme solution, and 250 mM citrate buffer (pH 4.5) was used as the buffer. Other conditions are the same as (a).

(ホ)Aspergillus oryzae GlcNAcase阻害試験法
(イ)の方法に準じて、緩衝液および酵素溶液を以下のように変更した。即ち、GlcNAcase酵素溶液としてAspergillus oryzae由来β-N−アセチルヘキソサミニダーゼ(SIGMA社)を、緩衝液として0.025%のBSAと250mMのNaClを含む250mMクエン酸緩衝液(pH5.0)を用いた。他の条件は(イ)に同じである。
(E) Aspergillus oryzae GlcNAcase inhibition test method The buffer solution and the enzyme solution were changed as follows according to the method of (a). That is, Aspergillus oryzae-derived β-N-acetylhexosaminidase (SIGMA) as a GlcNAcase enzyme solution, and 250 mM citrate buffer (pH 5.0) containing 0.025% BSA and 250 mM NaCl as a buffer solution. Using. Other conditions are the same as (a).

(ヘ)タチナタ豆(Jack bean) GlcNAcase阻害試験法
(イ)の方法に準じて、緩衝液および酵素溶液を以下のように変更した。即ち、GlcNAcase酵素溶液としてJack bean由来β-N−アセチルグルコサミニダーゼ(SIGMA社)を、緩衝液として、0.025%のBSAと250mMのNaClを含む250mMクエン酸緩衝液(pH5.0)を用いた。他の条件は(イ)に同じである。
(F) Tachinata Bean (Jack bean) GlcNAcase Inhibition Test Method The buffer solution and the enzyme solution were changed as follows according to the method (i). That is, Jack bean-derived β-N-acetylglucosaminidase (SIGMA) was used as the GlcNAcase enzyme solution, and 250 mM citrate buffer (pH 5.0) containing 0.025% BSA and 250 mM NaCl was used as the buffer. . Other conditions are the same as (a).

表1〜3にこれらの6種類の酵素阻害試験法をまとめる。

Figure 2007161690
Figure 2007161690
Figure 2007161690
Tables 1 to 3 summarize these six enzyme inhibition test methods.
Figure 2007161690
Figure 2007161690
Figure 2007161690

〔実施例1〕
スクリーニング
糸状菌916菌株、放線菌39菌株を任意に集め、適宜の培地、培養条件にて培養し、その培養物(培養ろ液、または、培養物の有機溶媒抽出物;有機溶媒としてアセトン/メタノール混合溶媒(1:1、v/v)またはn−ブタノールを使用)を、酵素阻害試験に供した。一次スクリーニングとして、昆虫ハスモンヨトウ蛹由来のGlcNAcaseを阻害する試料を選抜した。次に、これらの活性試料を、ほ乳類である子牛腎臓由来β-N−acetylglucosaminidase(GlcNAcase)阻害試験に供し、本酵素を阻害しない試料を選抜した。このようなスクリーニング系により、昆虫のGlcNAcaseを特異的に阻害する活性菌株、Streptomyces anulatus NBRC13369株(研究用に購入した株)を見出した。
[Example 1]
Screening 916 strains of filamentous fungi and 39 strains of actinomycetes are arbitrarily collected and cultured under appropriate medium and culture conditions, and the culture (culture filtrate or organic solvent extract of the culture; acetone / methanol as the organic solvent) Mixed solvents (1: 1, v / v) or n-butanol were used for enzyme inhibition tests. As a primary screening, a sample that inhibits GlcNAcase derived from the insect moth Spodoptera litura was selected. Next, these active samples were subjected to β-N-acetylglucosaminedase (GlcNAcase) inhibition test derived from calf kidney, which is a mammal, and samples that did not inhibit this enzyme were selected. By such a screening system, an active strain that specifically inhibits insect GlcNAcase, Streptomyces anuratus NBRC13369 strain (strain purchased for research) was found.

〔実施例2〕
活性物質の発酵生産
全ての培地は、使用前に120℃、20分間の滅菌操作を行った。
(i)菌株保存培地
菌株保存培地として、L−Asparagine 1g、Glycerol 10g、 KHPO1g、蒸留水1L、FeSO・7HO 0.001g、MnCl・4HO 0.001g、ZnSO・7HO 0.001g、寒天20gからなる培地を用いた。なお、滅菌前の培地はpH7.2に調整した。
(ii)発酵生産
Streptomyces anulatus NBRC13369株保存スラントの一白金耳を、glucose10g、NZ Amine typeA 2.0g(和光純薬工業株式会社製)、yeast extract 1.0 g(ナカライ社製)、beaf
extract 1.0g(DIFCO社製)、蒸留水1Lよりなる液体培地10mL(pH7.0)に接種し、28℃、300strokes/minにて二日間往復振盪培養し、種培養とした。次いで、生産培地として、コロイダルキチン5.0g、NZ Amine typeA 2.0g(和光純薬工業株式会社製)、yeast extract 1.0g(ナカライ社製)、beaf extract 1.0g(DIFCO社製)、蒸留水1Lからなる培地を1L坂口フラスコに300mLずつ分注し、前記種培地全量を添加し、28℃、123strokes/minの条件下で14日間培養した。培養終了後、培養液6.9Lをろ過し、菌体と培養ろ液に分別した。
[Example 2]
Fermentative production of active substances All media were sterilized at 120 ° C. for 20 minutes before use.
(I) Strain preservation medium As a strain preservation medium, 1 g of L-Asparagine, 10 g of Glycerol, 1 g of K 2 HPO 4, 1 L of distilled water, 0.001 g of FeSO 4 .7H 2 O, 0.001 g of MnCl 2 .4H 2 O, ZnSO A medium composed of 0.001 g of 4.7H 2 O and 20 g of agar was used. The medium before sterilization was adjusted to pH 7.2.
(Ii) Fermentation production Streptomyces anuratus NBRC 13369 strain preserved one platinum ear, glucose 10g, NZ Amine typeA 2.0g (manufactured by Wako Pure Chemical Industries, Ltd.), yeast extract 1.0 g (manufactured by Nacalai), beaf
Extract 1.0 g (manufactured by DIFCO) and 10 mL (pH 7.0) of a liquid medium composed of 1 L of distilled water was inoculated and subjected to reciprocal shaking culture at 28 ° C. and 300 strokes / min for 2 days to obtain seed culture. Next, as production media, colloidal chitin 5.0 g, NZ Amine type A 2.0 g (manufactured by Wako Pure Chemical Industries, Ltd.), yeast extract 1.0 g (manufactured by Nakarai Co., Ltd.), beef extract 1.0 g (manufactured by DIFCO), A medium consisting of 1 L of distilled water was dispensed in a volume of 300 mL into a 1 L Sakaguchi flask, the whole amount of the seed medium was added, and cultured under conditions of 28 ° C. and 123 strokes / min for 14 days. After completion of the culture, 6.9 L of the culture solution was filtered and separated into cells and culture filtrate.

なお、上記コロイダルキチン(コロイド状のキチン)は、”Improved bioassay method for Spodoptera litura chitinase inhibitors using acolloidal chitin powder with a uniform particle size as substrate. T. Nitoda, H, Kurumatani,H. Kanzaki, and K. Kawazu, Pesticide Science, Vol. 55, 563−565”に記載の方法に、多少の改良を加えて、次の通り調製した。すなわち、キチン粉末(和光純薬、1級、Lot.0796)2.5gを、冷却(氷中、寒剤)した35%塩酸100mLにスターラーで撹拌しながら、4〜5分かけて少量ずつ添加した。さらに、その液をスターラーで10分間撹拌し、氷中から出して撹拌しながら室温まで加温した。またさらに、その液を30℃で60分間、スターラーで撹拌し、吸引ろ過(SHIBATA3G3ガラスフィルター、ポアサイズ40〜100μm)した。そのろ液を脱塩水(2℃)1Lにスターラーで撹拌しながら注ぎ、4℃で一晩静置した。デカンテーションで上清を除去(容量300mL程度)した後、0.5N水酸化ナトリウムで氷中pH7.0になるよう中和し、吸引ろ過(SHIBATA25GP100ガラスフィルター、ポアサイズ40〜100μm)した。その残渣をかき集めて水道水に懸濁し、スターラーで3分間撹拌し、水道水(流水、室温)で一晩透析(Viskase Companies,Inc.36/32(φ27mm))した。さらに、脱塩水2Lを外液として4℃で3時間透析し、またさらに脱塩水2Lを外液として4℃で一晩透析した。その後、透析内液を、13,000rpmで10分間遠心分離(RPR20−2)することにより、キチンを回収した。回収キチンを18時間凍結乾燥し、コロイダルキチン粉末1.448gを得た。   Incidentally, the colloidal chitin (colloidal chitin) is, "Improved bioassay method for Spodoptera litura chitinase inhibitors using acolloidal chitin powder with a uniform particle size as substrate. T. Nitoda, H, Kurumatani, H. Kanzaki, and K. Kawazu , Pesticide Science, Vol. 55, 563-565 ", with some modifications and prepared as follows. That is, 2.5 g of chitin powder (Wako Pure Chemicals, grade 1, Lot. 0796) was added in small portions over 4 to 5 minutes while stirring with a stirrer to 100 mL of cooled (in ice, cryogen) 35% hydrochloric acid. . Further, the liquid was stirred with a stirrer for 10 minutes, taken out of ice, and warmed to room temperature while stirring. Furthermore, the liquid was stirred with a stirrer at 30 ° C. for 60 minutes, and suction filtered (SHIBATA3G3 glass filter, pore size: 40 to 100 μm). The filtrate was poured into 1 L of demineralized water (2 ° C.) while stirring with a stirrer and allowed to stand at 4 ° C. overnight. After removing the supernatant by decantation (volume of about 300 mL), the solution was neutralized with 0.5N sodium hydroxide to pH 7.0 in ice, and suction filtered (SHIBATA25GP100 glass filter, pore size: 40 to 100 μm). The residue was collected, suspended in tap water, stirred with a stirrer for 3 minutes, and dialyzed overnight against tap water (running water, room temperature) (Viskase Companies, Inc. 36/32 (φ27 mm)). Furthermore, 2 L of demineralized water was dialyzed at 4 ° C. for 3 hours as an external solution, and further dialyzed overnight at 4 ° C. using 2 L of demineralized water as an external solution. Then, chitin was collect | recovered by centrifuging a dialyzed internal solution at 13,000 rpm for 10 minutes (RPR20-2). The recovered chitin was lyophilized for 18 hours to obtain 1.448 g of colloidal chitin powder.

〔実施例3〕
活性物質の単離
(i)活性炭カラム
前記培養ろ液のうち5.5Lを、カラムクロマトグラフ用活性炭素(ナカライ社製)のカラム(6.5×33cm)に供し、1.1Lの脱塩水で洗浄後、0.01%のHClを含む30%アセトン2.5Lで有効成分を溶出し、阻害活性を示す画分を減圧濃縮してアセトンを留去し、1.4Lの水溶液を得た。この水溶液の一部を凍結乾燥したところ、この水溶液中の粗活性物質の総重量は4.7gと算出された(茶褐色吸湿性)。
(ii)陽イオン交換カラムおよび活性炭カラム(脱塩)
上記粗活性物質が溶解した水溶液全量(1.4L)を、Amberlite CG−50(H型)のカラム(6.5×31cm)に供し、2Lの脱塩水で洗浄後、0.1MのNaCl水溶液で有効成分を溶出し、阻害活性を示す画分を合一した。この合一画分を、カラムクロマトグラフ用活性炭素(ナカライ社製)のカラム(3.4×11cm)に供し、400mLの脱塩水で洗浄後、0.01%のHClを含む30%アセトン500mLで有効成分を溶出し、阻害活性を示す画分を減圧濃縮してアセトンを留去し、75mLの水溶液を得た。この水溶液全量を凍結乾燥し、茶褐色吸湿性の粗活性物質215mgを得た。
(iii)Sephadex LH−20カラム
上記粗活性物質全量(215mg)を、少量のメタノールに溶解し、あらかじめメタノールで平衡化したSephadex LH−20(ファルマシア社製)のカラム(1.0×50cm)に供し、メタノールで展開して阻害活性を示す画分を濃縮乾固し、茶褐色吸湿性の粗活性物質97.8mgを得た。
(iv)Asahipak ES 502C HPLC
上記粗活性物質全量(97.8mg)を860mLの水に溶解し、12回に分けて以下のカラムクロマトグラフィーに供した。即ち、あらかじめ7.5mM炭酸アンモニウム水溶液で平衡化した高速液体クロマトグラフィー(HPLC)用カラム(Shodex社製、Asahipak ES 502C 7C、7.6×100mm、流速0.8mL/ min)に、上記水溶液約70μLを供し、7.5mM炭酸アンモニウム水溶液で有効成分を溶出し、阻害活性を示す画分を凍結乾燥に供する事で、純粋な活性物質を白色粉末として40mg(分子式:C335920、分子量:831 FAB−MS(positive)m/z 831 (M))得た。この化合物を、以下活性物質Aと称する。
Example 3
Isolation of active substance (i) Activated carbon column 5.5 L of the culture filtrate was subjected to a column (6.5 × 33 cm) of activated carbon for column chromatography (manufactured by Nacalai), and 1.1 L of demineralized water The active ingredient was eluted with 2.5 L of 30% acetone containing 0.01% HCl, and the fraction showing the inhibitory activity was concentrated under reduced pressure to distill off the acetone to obtain a 1.4 L aqueous solution. . When a part of this aqueous solution was freeze-dried, the total weight of the crude active substance in this aqueous solution was calculated to be 4.7 g (brown hygroscopicity).
(Ii) Cation exchange column and activated carbon column (desalting)
The total amount (1.4 L) of the aqueous solution in which the crude active substance was dissolved was applied to an Amberlite CG-50 (H + type) column (6.5 × 31 cm), washed with 2 L of demineralized water, and then 0.1 M NaCl. The active ingredient was eluted with an aqueous solution, and fractions showing inhibitory activity were combined. This combined fraction is applied to a column (3.4 × 11 cm) of activated carbon for column chromatography (manufactured by Nakarai Co., Ltd.), washed with 400 mL of demineralized water, and then 500 mL of 30% acetone containing 0.01% HCl. The active ingredient was eluted with, the fraction showing inhibitory activity was concentrated under reduced pressure, and acetone was distilled off to obtain 75 mL of an aqueous solution. The total amount of this aqueous solution was lyophilized to obtain 215 mg of a brown hygroscopic crude active substance.
(Iii) Sephadex LH-20 column The total amount (215 mg) of the above crude active substance was dissolved in a small amount of methanol, and the column (1.0 × 50 cm) of Sephadex LH-20 (Pharmacia) equilibrated in advance with methanol. Then, the fraction showing inhibitory activity by developing with methanol was concentrated to dryness to obtain 97.8 mg of a brown hygroscopic crude active substance.
(Iv) Asahipak ES 502C HPLC
The total amount of the crude active substance (97.8 mg) was dissolved in 860 mL of water, and divided into 12 portions and subjected to the following column chromatography. That is, a column for high performance liquid chromatography (HPLC) (Shodex, Asahipak ES 502C 7C, 7.6 × 100 mm, flow rate 0.8 mL / min) previously equilibrated with 7.5 mM ammonium carbonate aqueous solution was added to the aqueous solution about 70 μL is applied, the active ingredient is eluted with 7.5 mM ammonium carbonate aqueous solution, and the fraction showing inhibitory activity is subjected to lyophilization, whereby 40 mg of pure active substance as white powder (molecular formula: C 33 H 59 O 20 N 4 , molecular weight: 831 FAB-MS (positive) m / z 831 (M) + ) was obtained. This compound is hereinafter referred to as active substance A.

〔試験例2〕
活性物質Aの構造解析
活性物質Aは、式(I−1)、式(I−2)、式(I−3)、および式(I−4)で示され、n=2である少なくとも4種類の異性体の平衡混合物である。以下に、構造解析に関する情報を示す。
(i)活性物質Aの糖組成分析
活性物質A(20μg)をメタノール分解に供し、その分解産物をN−アセチル化後、TMS誘導体化した。これをGC−FID分析に供したところ、1分子の活性物質Aから、約2分子のGlcNAc(N−アセチルグルコサミン)が検出された。よって、活性物質Aの構成糖として、GlcNAcの存在が明らかとなった。
(ii)活性物質Aの還元末端分析(ピリジルアミノ化)
活性物質Aを還元的ピリジルアミノ化(PA化)反応に供し、還元末端をPA化したPA化活性物質Aを調製した。これを酸加水分解し、N−アセチル化後、順相HPLC、逆相HPLC分析に供した。その結果、PA−GlcNAcが同定された。よって、活性物質Aの還元末端の糖残基をGlcNAcと同定した。
(iii)活性物質AのNMR分析
36mgの活性物質Aを750μlのCDOD(Dは重水素)に溶解し、30℃、 2日間のNMR分析に供したが、与えるスペクトルが非常に複雑であり、以下の情報が得られたのみであった。
(1) 3つのN−アセチル基が存在する。
(2) アノメリックプロトンが4種類存在することから考えて、重合度4のオリゴ糖である。
興味深いことに、本実験終了後の活性物質AをFAB−MS分析に供したところ、その分子量はm/z 832 [M]と観測された。つまり、分子量が1増加した。NMR測定溶媒にCDODを用いている事実から考えて、活性物質Aの一つのプロトンが重水素で置換されている可能性が強く示唆された。
次に、活性物質Aが還元性のオリゴ糖である事実から、これをSBH還元に供し、対応するアルジトール体を調製して、構造解析を進めた。なお、以降の構造解析実験には、重水素化された活性物質A(分子量832)を用いている。
[Test Example 2]
Structural analysis of active substance A Active substance A is represented by formula (I-1), formula (I-2), formula (I-3), and formula (I-4), and at least 4 where n = 2 An equilibrium mixture of different isomers. The information related to structural analysis is shown below.
(I) Sugar composition analysis of active substance A Active substance A (20 μg) was subjected to methanol decomposition, and the decomposition product was N-acetylated and then TMS-derivatized. When this was subjected to GC-FID analysis, about 1 molecule of GlcNAc (N-acetylglucosamine) was detected from 1 molecule of active substance A. Therefore, the presence of GlcNAc as a constituent sugar of active substance A was clarified.
(Ii) Analysis of reducing end of active substance A (pyridylamination)
Active substance A was subjected to a reductive pyridylamination (PA) reaction to prepare PA-activated active substance A in which the reducing end was converted to PA. This was subjected to acid hydrolysis, N-acetylation, and then subjected to normal phase HPLC and reverse phase HPLC analysis. As a result, PA-GlcNAc was identified. Therefore, the sugar residue at the reducing end of active substance A was identified as GlcNAc.
(Iii) NMR analysis of active substance A 36 mg of active substance A was dissolved in 750 μl of CD 3 OD (D is deuterium) and subjected to NMR analysis at 30 ° C. for 2 days. Yes, only the following information was obtained.
(1) There are three N-acetyl groups.
(2) Considering that there are four types of anomeric protons, it is an oligosaccharide having a degree of polymerization of 4.
Interestingly, when the active substance A after the completion of this experiment was subjected to FAB-MS analysis, its molecular weight was observed as m / z 832 [M] + . That is, the molecular weight increased by 1. Considering the fact that CD 3 OD is used as the NMR measurement solvent, the possibility that one proton of the active substance A is substituted with deuterium was strongly suggested.
Next, based on the fact that the active substance A is a reducing oligosaccharide, this was subjected to SBH reduction, and the corresponding alditol was prepared to proceed with the structural analysis. In the subsequent structural analysis experiments, deuterated active substance A (molecular weight 832) is used.

〔実施例4〕
活性物質Aアルジトール体の調製
5.18mgの活性物質AをSBH還元に供し、その反応物を活性炭カラムにて粗精製後、陽イオン交換HPLC、グラファイトカーボンHPLCにて順次精製したところ、対応するアルジトール体と考えられる2種類の化合物、活性物質A−1−ol(0.86mg)、および、活性物質A−2−ol(2.88mg)が得られた。つまり、活性物質Aは2種類の還元体を与える。よって、インタクトな活性物質Aは少なくとも4種類の異性体の平衡混合物であり、この平衡が還元反応により止まり、2種類の還元物を与えたものであると考えられる。
Example 4
Preparation of active substance A alditol body 5.18 mg of active substance A was subjected to SBH reduction, and the reaction product was roughly purified on an activated carbon column and then purified sequentially by cation exchange HPLC and graphite carbon HPLC. Two kinds of compounds considered to be a body, active substance A-1-ol (0.86 mg) and active substance A-2-ol (2.88 mg) were obtained. That is, the active substance A gives two types of reductants. Therefore, it is considered that the intact active substance A is an equilibrium mixture of at least four isomers, and this equilibrium is stopped by the reduction reaction to give two types of reductants.

(i)活性物質A−1−olおよび活性物質A−2−olの糖組成分析およびアルジトール部分の同定
40μgの活性物質A−1−ol、40μgの活性物質A−2−olをそれぞれメタノール分解に供し、その分解産物をN−アセチル化後、TMS化し、これをGC−FID分析に供した。その結果、活性物質A−1−olからは、GlcNAc(N−アセチルグルコサミン)およびManNAc(N−アセチルマンノサミン)アルジトールが2:1の比率で検出された。一方、活性物質A−2−olからは、GlcNAcおよびManNAcアルジトールが1:1の比率で検出された。よって、これらの2種類のアルジトール体は、還元末端由来のアルジトール部分の構造が異なっている事実が判明した。さらに、検出されたGlcNAcの比率がこれらの2種類のアルジトール間において異なる事実から考えて、グリコシド結合の安定性も異なる可能性が強く示唆された。
(I) Sugar composition analysis of active substance A-1-ol and active substance A-2-ol and identification of alditol moiety 40 μg of active substance A-1-ol and 40 μg of active substance A-2-ol were decomposed with methanol, respectively. The degradation product was subjected to N-acetylation and then converted to TMS, which was subjected to GC-FID analysis. As a result, GlcNAc (N-acetylglucosamine) and ManNAc (N-acetylmannosamine) alditol were detected from the active substance A-1-ol at a ratio of 2: 1. On the other hand, from the active substance A-2-ol, GlcNAc and ManNAc alditol were detected at a ratio of 1: 1. Therefore, it was found that these two types of alditols differ in the structure of the alditol moiety derived from the reducing end. Furthermore, in view of the fact that the ratio of detected GlcNAc differs between these two types of alditols, it was strongly suggested that the stability of glycosidic bonds may also be different.

(ii)活性物質A−2−olのMS分析
これら2種類のアルジトール体のうち、量的に多い活性物質A−2−olをLR−FAB MS、HR−FAB MS分析に供し、以下の結果を得た。
活性物質A−2−ol;LR−FAB MS m/z 834 [M],HR−FAB MS calcd for C336020 [M] 834.3942,found 834.3962
つまり、活性物質Aの1重水素置換体のアルジトール体に一致する分子量および組成式が得られた。
次に、活性物質A−2−olのNMR解析を行った。
(Ii) MS analysis of active substance A-2-ol Among these two types of alditols, quantitatively active substance A-2-ol was subjected to LR-FAB MS, HR-FAB MS analysis, and the following results Got.
LR-FAB MS m / z 834 [M] + , HR-FAB MS calcd for C 33 H 60 D 1 O 20 N 4 [M] + 834.3394, found 834.3396
That is, a molecular weight and a composition formula corresponding to the alditol form of the deuterium substitution product of the active substance A were obtained.
Next, NMR analysis of the active substance A-2-ol was performed.

(iii)活性物質A−2−olのNMR解析
活性物質A−2−ol、2mgをCDOD、DO中にて各種NMR測定に供し、以下の構造式を得た。

Figure 2007161690
つまり、活性物質A−2−olは、N−trimethyl glucosamineにGlcNAc−(β1,4)−GlcNAc−(β1,4)−GlcNAcがα−1−4結合した化合物の還元体であり、さらに、そのアルジトール部分の2位のメチンプロトンは重水素で置換されている事実が判明した。 (Iii) NMR analysis of active substance A-2-ol Active substance A-2-ol, 2 mg was subjected to various NMR measurements in CD 3 OD and D 2 O to obtain the following structural formula.
Figure 2007161690
That is, the active substance A-2-ol is a reduced form of a compound in which GlcNAc- (β1,4) -GlcNAc- (β1,4) -GlcNAc is α-1-4 linked to N-trimethyl glucosamine, It was found that the methine proton at the 2-position of the alditol moiety was substituted with deuterium.

(iv)活性物質A−1−olのNMR解析
次に、量的に少ない活性物質A−1−ol、0.7mgをDO中にて各種NMR測定に供し、以下の構造式

Figure 2007161690
を得た。
つまり、活性物質A−1−olは、N−triMe−glucosamineにGlcNAc−(β1,4)−GlcNAc−(β1,4)−ManNAcがα−1−4結合した化合物の還元体であり、さらに、そのManNAcアルジトール部分の2位のメチンプロトンは重水素で置換されている事実が判明した。 (Iv) NMR analysis of active substance A-1-ol
Next, a small amount of the active substance A-1-ol, 0.7 mg was subjected to various NMR measurements in D 2 O, and the following structural formula
Figure 2007161690
Got.
That is, the active substance A-1-ol is a reduced form of a compound in which GlcNAc- (β1,4) -GlcNAc- (β1,4) -ManNAc is α-1-4 linked to N-triMe-glucosamine. It was found that the methine proton at the 2-position of the ManNAc alditol moiety was replaced with deuterium.

次に上記解析の流れを示す。

Figure 2007161690
Next, the flow of the above analysis is shown.
Figure 2007161690

活性物質Aは、以下の3点から非常に興味深い新規化合物である。
(1)N−triMe−glucosamine残基を含むオリゴ糖として、天然から初めて単離された化合物である。
(2)異常糖部分であるN−triMe−glucosamine自体が、これまでに天然から報告された例はない。
(3)還元末端のN−acetylglucosamine部分が自然条件下で異性化し得ることを実証した初めての例である。
Active substance A is a very interesting new compound from the following three points.
(1) A compound isolated for the first time from nature as an oligosaccharide containing an N-triMe-glucosamine residue.
(2) N-triMe-glucosamine itself, which is an abnormal sugar moiety, has never been reported from nature.
(3) This is the first demonstration demonstrating that the N-acetylglucosamine moiety at the reducing end can be isomerized under natural conditions.

〔試験例3〕
活性物質Aの酵素阻害活性
重水素置換が生じていない、インタクトな活性物質Aを用いて、各種生物種由来GlcNAcaseに対する酵素阻害活性の有無を判定した。対照化合物として放線菌Streptomyce amakusaensisが生産するnagstatinを用いた。酵素阻害試験方法は試験例1の方法と同じである。
表4に測定結果を示す。表4から明らかなように、活性物質Aは昆虫、糸状菌由来のGlcNAcaseを特異的に阻害するのに対し、既知のGlcNAcase阻害剤であるnagstatinは、昆虫、糸状菌、ほ乳類、植物由来のGlcNAcaseを広く阻害する傾向を示した。このような狭い阻害特異性をしめすGlcNAcase阻害剤はこれまでに報告がないため、活性物質Aは、その構造、生理活性の両面で新規化合物であるといえる。

Figure 2007161690
[Test Example 3]
Enzyme inhibitory activity of active substance A Using the intact active substance A in which deuterium substitution did not occur, the presence or absence of enzyme inhibitory activity against various species-derived GlcNAcase was determined. As a control compound, nagstatin produced by Streptomyces amakusaensis was used. The enzyme inhibition test method is the same as that of Test Example 1.
Table 4 shows the measurement results. As is clear from Table 4, active substance A specifically inhibits GlcNAcase from insects and filamentous fungi, whereas nagstatin, a known GlcNAcase inhibitor, is GlcNAcase from insects, filamentous fungi, mammals and plants. Showed a tendency to obstruct widely. Since there has been no report on a GlcNAcase inhibitor exhibiting such a narrow inhibitory specificity, it can be said that the active substance A is a novel compound in terms of both its structure and physiological activity.
Figure 2007161690

〔試験例4〕
活性物質A−1−olおよび活性物質A−2−olの酵素阻害活性
試験例3と同様にして、活性物質A−1−olおよび活性物質A−2−olの酵素阻害活性のハスモンヨトウ蛹GlcNAcaseに対する阻害活性を測定して、表5にその結果を示す。

Figure 2007161690
[Test Example 4]
Enzyme inhibitory activity of active substance A-1-ol and active substance A-2-ol In the same manner as in Test Example 3, the enzyme inhibitory activity of active substance A-1-ol and active substance A-2-ol The inhibitory activity was measured, and the results are shown in Table 5.
Figure 2007161690

本発明は、殺虫作用および殺菌作用を示し、安全な農園芸用薬剤または食品添加剤の原料として有用な新規化合物を提供する。
The present invention provides a novel compound which exhibits an insecticidal action and a bactericidal action and is useful as a raw material for safe agricultural and horticultural drugs or food additives.

Claims (6)

式I
Figure 2007161690
(式I中、nは0〜5の整数、Xは対アニオンを表す。)
または、式II
Figure 2007161690
(式II中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
で示される化合物。
Formula I
Figure 2007161690
(In formula I, n represents an integer of 0 to 5, and X represents a counter anion.)
Or the formula II
Figure 2007161690
(In formula II, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
A compound represented by
式I
Figure 2007161690
(式I中、nは0〜5の整数、Xは対アニオンを表す。)
または、式II
Figure 2007161690
(式II中、nは0〜5の整数、Xは対アニオン、Rは水素Hまたは重水素Dを表す。)
で示される化合物を含有する殺虫性または殺菌性組成物。
Formula I
Figure 2007161690
(In formula I, n represents an integer of 0 to 5, and X represents a counter anion.)
Or the formula II
Figure 2007161690
(In formula II, n represents an integer of 0 to 5, X represents a counter anion, and R represents hydrogen H or deuterium D.)
An insecticidal or bactericidal composition containing the compound represented by:
農薬用または園芸用であることを特徴とする、請求項2に記載の組成物。   The composition according to claim 2, wherein the composition is for agricultural chemicals or horticulture. 食品添加剤用であることを特徴とする、請求項2に記載の組成物。   The composition according to claim 2, wherein the composition is for food additives. 請求項1に記載の化合物を含有することを特徴とする食品。   A food comprising the compound according to claim 1. 請求項1に記載の化合物を産生し得る微生物を培養し、その培養物から請求項1に記載の化合物を取得することを特徴とする、請求項1に記載の化合物の製造方法。
A method for producing the compound according to claim 1, wherein a microorganism capable of producing the compound according to claim 1 is cultured, and the compound according to claim 1 is obtained from the culture.
JP2005364111A 2005-12-16 2005-12-16 Compound having β-N-acetylglucosaminidase inhibitory activity Expired - Fee Related JP5049489B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005364111A JP5049489B2 (en) 2005-12-16 2005-12-16 Compound having β-N-acetylglucosaminidase inhibitory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005364111A JP5049489B2 (en) 2005-12-16 2005-12-16 Compound having β-N-acetylglucosaminidase inhibitory activity

Publications (2)

Publication Number Publication Date
JP2007161690A true JP2007161690A (en) 2007-06-28
JP5049489B2 JP5049489B2 (en) 2012-10-17

Family

ID=38244995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005364111A Expired - Fee Related JP5049489B2 (en) 2005-12-16 2005-12-16 Compound having β-N-acetylglucosaminidase inhibitory activity

Country Status (1)

Country Link
JP (1) JP5049489B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105277649A (en) * 2015-11-11 2016-01-27 湖南农业大学 Method for rapidly detecting activity of theanine and glutamine hydrolase in tea trees

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6486883A (en) * 1987-08-06 1989-03-31 Maikuroraifu Technic Inc Method for manufacturing yeast- and fungus-inhibiting product
JPH02117389A (en) * 1988-09-23 1990-05-01 Microlife Technics Inc Production of anti-fungus product and inhibition of growth of fungus
JPH04209787A (en) * 1990-12-11 1992-07-31 Koopu Chem Kk Soil blight controlling material and controlling method using the same
JPH0680531A (en) * 1992-07-15 1994-03-22 Koopu Chem Kk Material for controlling diseases damage of soil
JPH06503960A (en) * 1990-12-10 1994-05-12 ジェネンコア インターナショナル インコーポレーテッド Improved saccharification of cellulose by cloning and amplification of β-glucosidase gene of TRICHODERMA REESEI
JPH11292725A (en) * 1998-04-13 1999-10-26 Sumitomo Metal Mining Co Ltd Antimicrobial agent, its production and antimicrobial treatment
JP2003040711A (en) * 2001-07-25 2003-02-13 Sumitomo Chem Co Ltd Antibacterial agent
WO2005102059A1 (en) * 2004-04-23 2005-11-03 Asahi Breweries, Ltd. Control agent for disease caused by plant filamentous fungus, method of controlling disease caused by plant filamentous fungus and fertilizer therefor

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6486883A (en) * 1987-08-06 1989-03-31 Maikuroraifu Technic Inc Method for manufacturing yeast- and fungus-inhibiting product
JPH02117389A (en) * 1988-09-23 1990-05-01 Microlife Technics Inc Production of anti-fungus product and inhibition of growth of fungus
JPH06503960A (en) * 1990-12-10 1994-05-12 ジェネンコア インターナショナル インコーポレーテッド Improved saccharification of cellulose by cloning and amplification of β-glucosidase gene of TRICHODERMA REESEI
JPH04209787A (en) * 1990-12-11 1992-07-31 Koopu Chem Kk Soil blight controlling material and controlling method using the same
JPH0680531A (en) * 1992-07-15 1994-03-22 Koopu Chem Kk Material for controlling diseases damage of soil
JPH11292725A (en) * 1998-04-13 1999-10-26 Sumitomo Metal Mining Co Ltd Antimicrobial agent, its production and antimicrobial treatment
JP2003040711A (en) * 2001-07-25 2003-02-13 Sumitomo Chem Co Ltd Antibacterial agent
WO2005102059A1 (en) * 2004-04-23 2005-11-03 Asahi Breweries, Ltd. Control agent for disease caused by plant filamentous fungus, method of controlling disease caused by plant filamentous fungus and fertilizer therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105277649A (en) * 2015-11-11 2016-01-27 湖南农业大学 Method for rapidly detecting activity of theanine and glutamine hydrolase in tea trees

Also Published As

Publication number Publication date
JP5049489B2 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
AU607166B2 (en) Agents for combating pests and plant treatment agents
TWI251465B (en) A novel strain of streptomyces for controlling plant diseases
Rabea et al. Insecticidal and fungicidal activity of new synthesized chitosan derivatives
EP0794704B1 (en) Granulates containing micro-organisms
CN103889464B (en) Anti-microbial agents with n-nonanoic acid
UA102527C2 (en) Insectidal combination of active agents, using thereof and seeds
JPH0539207A (en) Noxious organism controlling agent for plant
KR20190054871A (en) Composition for controlling plant diseases including Trevesia palmata, fraction of thereof or a compound isolated therefrom as an active ingredient and method of controlling plant diseases using the same
MARQUES et al. Antimicrobial and insecticidal activities of cashew tree gum exudate
JPH032876B2 (en)
TWI775848B (en) Methods of pest control
KR920000860B1 (en) Physiologically active agent for agricultural use
JP5049489B2 (en) Compound having β-N-acetylglucosaminidase inhibitory activity
KR20170054894A (en) Composition for controlling root knot nematode comprising kojic acid as effective component and uses thereof
JPH10500283A (en) Fungicidal toxins from biological control bacteria
KR20190050037A (en) Antimicrobial composition including extract of schizophyllum commune strain culture and preparing method thereof
JP2664464B2 (en) Method for controlling aflatoxin contamination using iturin-A
US4868203A (en) Bacterial substance and pharmaceutical composition thereof
ApSimon et al. Mycotoxins from Fusarium species: detection, determination and variety
JP4636623B2 (en) Compound having N-acetylglucosaminidase inhibitory activity
US20140128257A1 (en) Pesticidal compositions comprising 4,5-dihydroxyindan-1-one
EL-Ashmony Biological and chemical control of sunflower basal stem rot caused by Sclerotium rolfsii
KR20240020308A (en) Novel Burkholderia sp. having nematicidal activity and use thereof
DE3607287A1 (en) Process for the preparation of borrelidin and its use as pesticide
WO1999007226A1 (en) Vegetable-base soil fungicides, mycelial plant regulators, and method for regulating soil

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080701

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20090422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111018

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120321

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120412

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120710

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120723

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150727

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees